Mayo Clinic Cardiologist, Jay Shah, M.D. Joins MicroSalt Advisory Board

Dr. Shah, a leader in cardiovascular medicine, joins the science advisory board as the medical advisor to the MicroSalt team.

MicroSalt is pleased to announce a new member of its advisory board. Jay Shah, M.D. Shah joins MicroSalt Inc. as a medical advisor who will provide valuable insight as the MicroSalt team continues forward on its mission to reduce sodium consumption and offer healthier alternatives for consumers.

“We’re excited to have Dr. Shah join our advisory board,” said Victor Hugo Manzanilla, CEO of MicroSalt. “His wealth of experience as a cardiologist and startup investor puts him in a unique position to advise our team as we grow.”

Dr. Shah comes to the team with more than a decade of experience in cardiovascular medicine, and currently serves as a senior associate consultant with the Mayo Clinic and assistant professor at Mayo Clinic Alix School of Medicine. Within the startup community, he has served as an independent investor and advisor to more than a dozen startups and private companies.

“As an investor and advisor, I look for ideas and companies that have the potential to impact our world in a meaningful way,” Dr. Shah said. “MicroSalt is poised to be part of a larger solution to reducing our consumption of sodium and the negative health consequences associated with our excessive intake of salt.”

MicroSalt aims to revolutionize the food industry with a patented sodium nanoparticle engineered to deliver the full flavor experience of salt with half the sodium. MicroSalt’s powdered salt particles are approximately 100 times smaller than regular table salt, allowing them to be rapidly dissolved. MicroSalt is all-natural, non-GMO, and Kosher.